Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD,

Published byLiliana Leszczyńska Modified over 5 years ago

Similar presentations

Presentation on theme: "Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD,"— Presentation transcript:

1 Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD, Michael I. Ebright, MD, Allan J. Walkey, MD, Hiran C. Fernando, MBBS, Ken S. Zaner, MD, PhD, Donna M. Morelli, BS, Lisa A. Kachnic, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 6, Pages (June 2011) DOI: /j.jtcvs Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 A, Kaplan–Meier curves showing adjusted survival for patients in the Chemo-RT and Surg groups. Survival difference is significant (P = .000). B, Kaplan–Meier survival curves for Chemo-RT and Surg subgroups: surgery alone (17), surgery and adjuvant external radiation therapy (19), and external radiation therapy followed by surgery (21). Survival differences are significant (P = .0001). XRT, External radiation therapy. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node- negative T3 and T4 non–small cell lung cancer  Benedict D.T. Daly, MD,"

Similar presentations

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer  Gaurav S. Ajmani, MHS, Chi-Hsiung.

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer  Gaurav S. Ajmani, MHS, Chi-Hsiung.
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system  Shamus R.
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
How should we treat air leaks?

How should we treat air leaks?
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized.

Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: Results from the ACOSOG Z4032 (Alliance) multicenter randomized.
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology  Sarita Dubey, MD, Giorgio Scagliotti,

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology  Sarita Dubey, MD, Giorgio Scagliotti,

Similar presentations

Ads by Google